statement for the year 2018, attached please find the Management Discussion and Analysis (MD&A) of the year 2018. This report should be considered in conjunction with the submitted financial statements in
the Consolidated Financial Statements ended 31 December 2019, which have been audited by the Company’s authorized auditor. The Company would like to clarify the operating results of the Company and its
receiving replacement therapy with dialysis by dialysis machinery (Dialysis Center) and distribution of medical tools and equipment. . Overview of operating results in the Quarter /. Overall global economy
of lower utilization rate; and 3) higher finance costs due to higher borrowings as a result of previous investments in machinery, subsidiaries, and joint ventures. However, there is an improvement
enter search criteria Document Type -- Select Security Type -- Financial Statements Annual Registration Statement (Form 56-1) Annual Report (Form 56-2) Key Financial Ratio Issuer / Underlying / Securities
search criteria Document Type -- Select Security Type -- Financial Statements Annual Registration Statement (Form 56-1) Annual Report (Form 56-2) Key Financial Ratio Issuer / Underlying / Securities Date
criteria Document Type -- Select Security Type -- Financial Statements Annual Registration Statement (Form 56-1) Annual Report (Form 56-2) Key Financial Ratio Issuer / Underlying / Securities Date From To